CY1106089T1 - Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα - Google Patents

Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα

Info

Publication number
CY1106089T1
CY1106089T1 CY20061100695T CY061100695T CY1106089T1 CY 1106089 T1 CY1106089 T1 CY 1106089T1 CY 20061100695 T CY20061100695 T CY 20061100695T CY 061100695 T CY061100695 T CY 061100695T CY 1106089 T1 CY1106089 T1 CY 1106089T1
Authority
CY
Cyprus
Prior art keywords
androgens
preparation
topical application
substances acting
treatment
Prior art date
Application number
CY20061100695T
Other languages
English (en)
Inventor
Karl Theodor Kraemer
Manfred Bohn
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998148856 external-priority patent/DE19848856A1/de
Priority claimed from DE1999100749 external-priority patent/DE19900749A1/de
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1106089T1 publication Critical patent/CY1106089T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Abstract

Σκεύασμα που περιέχει τουλάχιστον μια φυσιολογικά συμβατή ουσία σχηματισμού μεμβράνης, τουλάχιστον έναν φυσιολογικά συμβατό διαλύτη, τουλάχιστον έναν πλαστικοποιητή και μια ένωση του τύπου (I) είναι κατάλληλη για τη θεραπεία της ανδρογόνου αλωπεκίας, του δασυτριχισμού των γυναικών ανδρικού τύπου, δηλ. για την αποφυγή της ανεπιθύμητης τριχοφυΐας και τη θεραπεία σμηγματόρροιας και της ακμής και περαιτέρω μπορεί να χρησιμοποιηθεί στη βιομηχανία καλλυντικών.
CY20061100695T 1998-10-23 2006-06-01 Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα CY1106089T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998148856 DE19848856A1 (de) 1998-10-23 1998-10-23 Zubereitungen zur topischen Applikation von antiandrogen wirksamen Subsatanzen
DE1999100749 DE19900749A1 (de) 1999-01-12 1999-01-12 Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
PCT/EP1999/007660 WO2000024366A1 (de) 1998-10-23 1999-10-12 Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen

Publications (1)

Publication Number Publication Date
CY1106089T1 true CY1106089T1 (el) 2011-06-08

Family

ID=26049702

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100695T CY1106089T1 (el) 1998-10-23 2006-06-01 Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα

Country Status (13)

Country Link
US (6) US20030083322A1 (el)
EP (1) EP1123082B1 (el)
JP (1) JP5162064B2 (el)
AT (1) ATE318578T1 (el)
AU (1) AU755165B2 (el)
CA (1) CA2347907C (el)
CY (1) CY1106089T1 (el)
DE (1) DE59913181D1 (el)
DK (1) DK1123082T3 (el)
ES (1) ES2258342T3 (el)
IL (2) IL142598A0 (el)
PT (1) PT1123082E (el)
WO (1) WO2000024366A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
JP2004504336A (ja) * 2000-07-26 2004-02-12 コグニス・フランス・ソシエテ・アノニム 体毛成長を抑制する相乗活性混合物
EP1515725A4 (en) * 2002-06-25 2005-09-21 Wyeth Corp USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED ILLNESSES
CA2489813A1 (en) * 2002-06-25 2003-12-31 Wyeth Use of thio-oxindole derivatives in treatment of hormone-related conditions
KR20050012831A (ko) * 2002-06-25 2005-02-02 와이어쓰 피부 질환을 치료하는 데 있어서의 티오-옥스인돌유도체의 용도
MXPA04012420A (es) * 2002-06-25 2005-04-19 Wyeth Corp Derivados de ciclotiocabamativa como moduladores de rp y uso de los mismos para tratamiento de trastornos de la piel.
DE202004000552U1 (de) * 2004-01-15 2004-04-01 Ivoclar Vivadent Ag Mittel zum Bleichen von Zähnen
AU2005209045B2 (en) * 2004-01-30 2011-02-24 Ace Aps Use of ACE inhibitors and/or angiotensin II receptor antagonists for the improving and/or maintaining the skin tone and for the treatment of skin ageing
EP1789031A2 (en) * 2004-08-18 2007-05-30 Ace ApS Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
CN105287484A (zh) 2007-11-30 2016-02-03 盖尔德马研究及发展公司 含有萘甲酸衍生物、过氧化苯甲酰和成膜剂的组合物
EP2153836A1 (en) * 2008-08-04 2010-02-17 Polichem S.A. Film-forming liquid formulations for drug release to hair and scalp
WO2010069519A1 (en) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
US20150313829A1 (en) * 2012-11-26 2015-11-05 Roberto Queiroga Lautner Topical formulations for the prevention and treatment of alopecia and inhibition of hair growth
DE102013226048A1 (de) * 2013-12-16 2015-06-18 Henkel Ag & Co. Kgaa Stylingspray mit Volumeneffekt
IT201900000484A1 (it) * 2019-04-23 2020-10-23 Neilos S R L Composizione per il trattamento dei disordini a carico dell’apparato uro-genitale femminile

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US5541220A (en) * 1984-03-07 1996-07-30 Ismail; Roshdy Agents for the treatment and protection of the skin
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
JPH082774B2 (ja) * 1987-02-05 1996-01-17 株式会社資生堂 〔ベンゾ−１，２，４−チアジアジン〕−１−ジオキシド誘導体溶解組成物
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
JP2733980B2 (ja) * 1988-08-26 1998-03-30 大正製薬株式会社 養毛組成物
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
AU659861B2 (en) * 1991-09-10 1995-06-01 Sansho Seiyaku Co., Ltd. Preparation for promoting hair growth
GB9210768D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
GB9210756D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
US5417984A (en) * 1992-12-14 1995-05-23 Biocontrol, Inc. Low crystallinity cellulose excipients
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
FR2706126B1 (fr) * 1993-06-08 1995-07-21 Oreal Composition cosmétique contenant un pseudo-latex ayant des propriétés de rémanence.
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
FR2719216B1 (fr) * 1994-05-02 1996-05-31 Oreal Composition pour le traitement et la protection des cheveux à base de céramides et de polymères de Vinylpyrrolidone.
JPH09512562A (ja) * 1994-05-05 1997-12-16 メルク フロスト カナダ インコーポレーテツド 局所性ポリマー薬物供給システム
JPH0812529A (ja) * 1994-06-23 1996-01-16 Riken Health Kk 透明養毛・育毛剤
ES2168392T3 (es) * 1994-12-02 2002-06-16 Kao Corp Derivados de flavanonol y compuesto estimulante para la nutricion y crecimiento del cabello que los contiene.
FR2729664A1 (fr) * 1995-01-20 1996-07-26 Cird Galderma Composes bicycliques-aromatiques a forte activite biologique compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2741342B1 (fr) * 1995-11-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
FR2742749B1 (fr) * 1995-12-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
FR2751965B1 (fr) * 1996-08-01 1998-11-27 Oreal Nouveaux composes de la famille des aryl-2,4-dioxo-oxazolidines
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
EP0966246A1 (de) * 1997-08-28 1999-12-29 Wella Aktiengesellschaft Zwei-komponenten kosmetisches pflegemittel
FR2770842B1 (fr) * 1997-11-13 1999-12-17 Oreal Nouveaux composes derives de n-aryl 2-hydroxy alkylamides

Also Published As

Publication number Publication date
IL142598A0 (en) 2002-03-10
EP1123082B1 (de) 2006-03-01
US20090093487A1 (en) 2009-04-09
PT1123082E (pt) 2006-06-30
US20050175647A1 (en) 2005-08-11
JP5162064B2 (ja) 2013-03-13
EP1123082A1 (de) 2001-08-16
JP2002528401A (ja) 2002-09-03
AU755165B2 (en) 2002-12-05
US20030083322A1 (en) 2003-05-01
AU1035900A (en) 2000-05-15
US20140142124A1 (en) 2014-05-22
ES2258342T3 (es) 2006-08-16
ATE318578T1 (de) 2006-03-15
DE59913181D1 (de) 2006-04-27
US20110065763A1 (en) 2011-03-17
WO2000024366A1 (de) 2000-05-04
CA2347907A1 (en) 2000-05-04
DK1123082T3 (da) 2006-06-26
IL142598A (en) 2006-04-10
US20120277235A1 (en) 2012-11-01
CA2347907C (en) 2009-12-08

Similar Documents

Publication Publication Date Title
CY1106089T1 (el) Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα
DE69533581D1 (de) Sprühbare zubereitungen enthaltend dispernierten pulvers sowie dessen anwendungsverfahren
KR101089071B1 (ko) 백모증 처리를 위한 엘라그산의 용도
DE59410330D1 (de) Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
ES2187390A1 (es) Un antiandrogeno topico para la perdida de cabello y otros estados hiperandrogenos.
ATE304840T1 (de) Hautpflegezusammensetzung
BR9500555A (pt) Composição cosméticas de uso tópico,processo de preparação de composições,utilização de composições e processo de tratamento cosmético
PT92966A (pt) Processo para a preparacao de uma composicao para acelarar o bronzeamento solar
KR100930257B1 (ko) 백모증 처리를 위한, 3ｈ-1,2-디티올-3-티온, 아네톨 디티올에티온, 설포라판, 펜에틸 이소티오시아네이트, 6-(메틸설피닐)헥실 이소티오시아네이트 및 알릴 이소티오시아네이트의 용도
AU5792399A (en) Stable ascorbic acid preparation for topical use
BR9916440B1 (pt) composiÇço tàpica, processo cosmÉtico para clareamento de pele humana e uso do Ácido linoleico conjugado e/ou derivados do mesmo.
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
RU95103437A (ru) Косметическая и/или дерматологическая композиция и способ борьбы с внутренним старением кожи
MY124480A (en) Use of glyceryl triacetate for treating onychomycoses
DE59904623D1 (de) Kosmetische und dermatologische zubereitungen, enthaltend erhöhte elektrolytkonzentrationen
KR100953848B1 (ko) 백모증 치료를 위한, 쿠마린 및 그의 유도체, 부틸화하이드록시아니솔 및 에톡시퀸의 용도
ATE269046T1 (de) Kosmetische zusammensetzung mit einer wismuthvanadat enthaltende kontinuierlicher hydophile phase
AU1542288A (en) Combination of minoxidil and an anti-inflammatory agent for treating patterned alopecia
CA2280985A1 (fr) Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
DE60010204T2 (de) Sonnenschutzzusammensetzungen und deren verwendung
DE60132102D1 (de) Melanogenese-hemmer und aufhellungsmittel mit einem ergosterol-derivat und ein ergosterol-derivat enthaltende zusammensetzungen
EP0875240A3 (de) Wirkstoffkombinationen bzw. Addukte aus Dibenzoylmethanderivaten und/oder Zimtsäurederivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Lichtschutzzubereitungen
BR9203266A (pt) Composto,formulacao farmaceutica,processo para inibir 5alfa-reductase,processos para tratar hiperplasia benigna da prostata,seborreia e alopecia androgenica
KR20030005258A (ko) 케라틴 물질의 화장용 처리에 있어서의 알콜디하이드로게나아제 저해제의 용도
BR0000627A (pt) Composição cosmética para uso tópico, uso da composição e processo de tratamento cosmético